Artwork for podcast The Stock Power Podcast
“Big 3” COVID-19 Vaccine Stocks: Buy, Hold or Run Far Way
Episode 8726th March 2021 • The Stock Power Podcast • Money & Markets
00:00:00 00:28:24

Share Episode

Shownotes

COVID-19 vaccines still dominate headlines.

And smart investors like you want to know: Should you be invested in any of the “first three” companies distributing approved vaccines?

This week, chief investment strategist Adam O’Dell, Green Zone Fortunes co-editor Charles Sizemore and I will break down Moderna Inc. (Nasdaq: MRNA), Pfizer Inc. (NYSE: PFE) and Johnson & Johnson (NYSE: JNJ).

We’ll discuss if any of these stocks will see a boost as COVID-19 vaccines continue to roll out.

Adam and Charles have been researching biotech and DNA stocks for more than a year. They’ve identified a top DNA play they think will profit from the coming DNA revolution the same way Intel stock skyrocketed with the mass adoption of the internet.
They also found three speculative DNA stocks that trade for under $10. They’ll give all the details to members of our monthly investment service, Green Zone Fortunes in the coming days.

Be sure to also subscribe to our YouTube channel for more videos like my weekly Marijuana Market Update.

Have something you want us to talk about? Email thebullandthebear@moneyandmarkets.com and give us your thoughts.

Check out moneyandmarkets.com, and sign up for our free newsletters that deliver you the most important and unbiased financial news, commentary, and actionable advice.

Also, follow us on:

Facebook

Twitter

LinkedIn

Chapters